Trial NCT04653389

View at ClinicalTrials.gov 
Org. Study IDs: CISLD-10

Last trial update was posted on 2022-01-11

MeSH Interventions

Immunomodulating Agents

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

The treatment efficacy was not satisfactory.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID